Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
Risk Stratification
100%
Pediatric Patients
100%
Rhabdomyosarcoma
100%
Molecular Detection
100%
Disseminated Infection
100%
95% Confidence Interval
83%
Quantitative PCR
66%
Event-free Survival
33%
Bone Marrow
33%
Dutch
16%
Risk Group Stratification
16%
Patient Cohort
16%
Clinical Outcomes
16%
Metastasizing
16%
Hazard Ratio
16%
5-year Survival
16%
Gene Expression Data
16%
Negatively Associated
16%
Recurrent Disease
16%
Peripheral Blood
16%
SNAI2
16%
Cox Regression Model
16%
Need for Improvement
16%
MyoD1
16%
PCR Detection
16%
Hematologic
16%
ACTC1
16%
CDH11
16%
PDLIM3
16%
Pax3
16%
ZIC1
16%
Progressive Disease
16%
MEGF10
16%
Marker Panel
16%
Working Diagnosis
16%
Forkhead Box Protein O1 (FOXO1)
16%
Pediatric Soft Tissue Sarcoma
16%
Multiplexed
16%
Peripheral Blood Samples
16%
Strong Association
16%
Tumor-derived
16%
Molecular Disease
16%
RNA Panel
16%
Multivariate Cox Regression
16%
TMEM47
16%
Medicine and Dentistry
Risk Stratification
100%
Pediatrics Patient
100%
Rhabdomyosarcoma
100%
Disseminated Disease
100%
Real-Time Polymerase Chain Reaction
66%
Reverse Transcriptase
66%
Event Free Survival
33%
Neoplasm
16%
Pediatrics
16%
High Risk Population
16%
Overall Survival
16%
Recurrent Disease
16%
Hazard Ratio
16%
Gene Expression
16%
Soft Tissue Sarcoma
16%
Progressive Disease
16%
Molecular Disease
16%
Messenger RNA
16%
Cox Regression Model
16%
Biochemistry, Genetics and Molecular Biology
Real-Time Polymerase Chain Reaction
100%
Reverse Transcriptase
100%
Pediatrics
100%
RNA
75%
Event Free Survival
50%
Candidate Gene
25%
High Risk Population
25%
Overall Survival
25%
Gene Expression Data
25%
SNAI2
25%
FOXO1
25%
PAX3
25%
Molecular Disease
25%
CDH11
25%
Messenger RNA
25%
ACTC1
25%
Immunology and Microbiology
Real-Time Polymerase Chain Reaction
100%
Reverse Transcriptase
100%
Ribonucleic Acid
75%
Event Free Survival
50%
Gene Expression
25%
Overall Survival
25%
High Risk Population
25%
Soft Tissue
25%